Bank Of Montreal Atri Cure, Inc. Transaction History

Bank Of Montreal

$214 Billion
Q3 2024

A detailed history of Bank Of Montreal transactions in Atri Cure, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 21,309 shares of ATRC stock, worth $767,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,309

Previous 21,441 0.62%

Holding current value

$767,763

Previous $488,000 22.34%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$20.34 - $29.5 $2,684 - $3,894	-132 Reduced 0.62%	21,309 $597,000
Q2 2024 Aug 14, 2024	BUY	$19.86 - $29.09 $16,503 - $24,173	831 Added 4.03%	21,441 $488,000
Q4 2023 Feb 08, 2024	SELL	$32.99 - $43.25 $2,936 - $3,849	-89 Reduced 0.43%	20,610 $735,000
Q3 2023 Nov 01, 2023	SELL	$41.12 - $57.73 $3,618 - $5,080	-88 Reduced 0.42%	20,699 $906,000
Q2 2023 Aug 02, 2023	BUY	$40.44 - $49.6 $1,981 - $2,430	49 Added 0.24%	20,787 $1.03 Million
Q1 2023 Jun 13, 2024	BUY	$35.87 - $47.22 $72,636 - $95,620	2,025 Added 9.83%	22,635 $938,000
Q4 2022 Feb 01, 2023	SELL	$33.48 - $47.45 $132,011 - $187,095	-3,943 Reduced 15.98%	20,738 $920,000
Q3 2022 Nov 10, 2022	BUY	$38.25 - $52.62 $756,470 - $1.04 Million	19,777 Added 403.28%	24,681 $1.07 Million
Q2 2022 Aug 11, 2022	BUY	$35.1 - $66.01 $4,422 - $8,317	126 Added 2.64%	4,904 $201,000
Q1 2022 May 12, 2022	SELL	$57.43 - $71.39 $32,160 - $39,978	-560 Reduced 10.49%	4,778 $311,000
Q4 2021 Feb 11, 2022	BUY	$63.4 - $87.14 $39,498 - $54,288	623 Added 13.21%	5,338 $373,000
Q3 2021 Nov 12, 2021	BUY	$69.28 - $84.46 $7,205 - $8,783	104 Added 2.26%	4,715 $330,000
Q2 2021 Aug 12, 2021	BUY	$64.13 - $80.18 $295,703 - $369,709	4,611 New	4,611 $370,000

Others Institutions Holding ATRC

# of Institutions

212

Shares Held

49.7M

Call Options Held

12K

Put Options Held

7.2K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.67B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account